Low back pain and FokI (rs2228570) polymorphism of vitamin D receptor in athletes by Cauci, Sabina et al.
RESEARCH ARTICLE Open Access
Low back pain and FokI (rs2228570)
polymorphism of vitamin D receptor in
athletes
Sabina Cauci1,4*, Francesca Migliozzi1,2, Carlo Simone Trombetta1, Ilaria Venuto1, Paola Saccheri3,
Luciana Travan3 and Giovanni Chiriacò2
Abstract
Background: Low back pain (LBP) is common in athletes. LBP can be detrimental to athletic performance and
health. Factors predisposing to LBP in athletes remain elusive and require further studies. We investigated whether
carriage of a specific genotype and/or allele of vitamin D receptor gene (VDR) FokI polymorphism (rs2228570) was
a risk factor for LBP in athletes of different sports disciplines.
Methods: This genotype/phenotype association case-control study included 60 Italian athletes (25 females and
35 males; mean age 33.9 ± 13.3 years; body-mass-index 23.5 ± 3.5 kg/m2) of which 16.7% were swimmers, 11.
7% soccer players, 11.7% volleyball players, 10.0% rugby players and other disciplines. VDR-FokI polymorphism
was measured by PCR-RFLP in 24 athletes with LBP and 36 athletes without LBP episodes. Absence or
presence of the FokI restriction site was denoted “F” and “f”, respectively. Other risk factors were evaluated by
a questionnaire.
Results: The homozygous FF genotype was found in 58.3% (14/24) of athletes with LBP versus 27.8% (10/36)
of athletes without LBP, adjusted OR = 5.78, 95% CI 1.41–23.8, P = 0.015. The F allele was a 2-fold risk factor to develop LBP,
adjusted OR = 2.55, 95% CI 1.02–6.43, P = 0.046, while f allele was protective. Exposure to vehicle vibrations ≥2 h daily, and
family history of lumbar spine pathology were significant risk factors for LBP with OR = 3.54, and OR = 9.21, respectively.
Conclusions: This is the first study in which an association between VDR-FokI polymorphism and LBP in athletes was
found. Further research is needed to extend our results, and to clarify the biochemical pathways associated with how
vitamin D modulates LBP in athletes. The VDR-FokI polymorphism should be considered when developing genetic
focused studies of precision medicine on health in athletes.
Keywords: Lumbar pain, Exercise, Vitamin D receptor, Vitamin D receptor gene, Vitamin D receptor polymorphism, FokI
polymorphism, Exposure to vibrations, Smoking and low back pain, Discopathies
Background
Low back pain (LBP) can have a significant impact on
athletes’ performance and may sometimes cause disabil-
ity [1–3]. LBP has been largely studied in the general
population; approximately 50–80% of people have at
least one episode during their lifetime [4–7]. Con-
versely, there are few studies focused on LBP in
athletes. In studies were lumbar spine pain is evalu-
ated as a symptom by questionnaire, it had a preva-
lence of around 30–40% [1, 2, 8]. Prevalence of LBP
seems to vary according to type of sport discipline
[9], rates over 70% were reported for bowling/skittles,
canoe, cycling, gymnastics, rowing, shooting, snow-
boarding, and volleyball [8]. A recent Iranian study
[10] among college female athletes found a life-time
prevalence of LBP of nearly 70% in basketball, karate,
and track-and-field athletes.
LBP has a complex etiology and it is often recurrent
[11–13]. In the general population many environmental/
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behavioral risk factors, including age, sex, weight, occu-
pational load, smoking and exposure to vehicle vibration
were demonstrated to contribute to spinal degeneration
and severe pain [7, 14, 15]. In athletes, exposure to high
exercise load [16], decreased lumbar flexion and exten-
sion, shoulder flexibility, and forward bending have been
involved in LBP and disc degeneration processes [1, 9, 17].
Recently, some epidemiologic and genetic studies [6, 7, 14,
15, 18–20] performed in the general non-athletic popula-
tion supported the notion that LBP and disc degeneration
disorders may be affected by genetic polymorphisms of
the vitamin D receptor gene (VDR) including FokI, BsmI,
TaqI and ApaI single nucleotide polymorphisms (SNPs).
Among several SNPs identified in the VDR gene, only
the FokI polymorphism is located in an exon sequence
[21, 22]. The FokI polymorphism (rs2228570) is a C to
T transition polymorphic site located in the VDR start
codon, affecting the amino acid sequence and the func-
tion of the encoded receptor protein [21]. The allelic
variants of this polymorphism code for structurally
different receptor proteins (from a 424 aminoacids wild
type encoded by the F allele to a 427 amino acid long
protein encoded by the f allele). The short and long pro-
tein variants are associated with a different efficiency of
VDR binding with the transcription factor II B (TFIIB)
and, thus, to a different ability to induce transcription of
VDR-dependent genes (vitamin D response elements,
VDREs [23]). The shorter wild protein (corresponding to
the F allele) appears to interact more efficiently with
TFIIB showing a higher transcriptional rate [24, 25].
Consequently, studies concerning the possible association
of VDR-FokI polymorphism with LBP and disc degener-
ation may be particularly interesting for the potential
biological significance. VDR-FokI is an independent
polymorphic site, not in linkage disequilibrium with other
VDR-SNPs [21]. Distribution of VDR-FokI polymorphism
genotypes and alleles can vary with the genetic back-
grounds. Therefore, specific ethnic group focused
studies are warranted [6].
Wide evidence supports the notion that the vitamin D
endocrine system, including active vitamin D hormone
(1α,25-dihydroxyvitamin D3), its receptor and the en-
zymes involved in the generation of the biologically-
active forms of vitamin D are implicated in the modulation
of different biological processes, including skeletal metabol-
ism, immunological response (in general, vitamin D/VDR
action promotes interleukin-1 and innate immune response,
while it attenuates adaptive immunity), detoxification, oxida-
tive stress, cancer-related metabolic pathways, proliferation
and differentiation of a wide variety of cell types [26, 27].
Recently, the presence of VDR was evident in skeletal
muscle [28, 29] and also in intervertebral disc cells, more
specifically in the nucleus pulposus and annulus fibrosus
cells, which constitute the two different major parts of the
intervertebral disc [30]. This highlighted that biological in-
teractions of intervertebral disc cells with the vitamin D me-
tabolites may be crucial to disc health, consequently an
altered vitamin D signaling could have a role in the patho-
physiology of the disc degeneration and LBP [6].
To our knowledge, there are no studies investigating
the association of the VDR-FokI polymorphism and LBP
in athletes. This polymorphism by changing the se-
quence and activity of the VDR protein could affect the
activity of the wide variety of genes modulated by the
VDR nuclear receptor. Identification of genetic traits in
athletes predisposing to LBP might help clinicians,
coaches, sport trainers, and athletes themselves to de-
velop personalized strategies to prevent or reduce LBP,
for example, by modification of some lifestyles habits
and/or kind of training.
The aims of this study were to evaluate the VDR-FokI
genotypic and allelic frequencies distribution in athletes
with LBP in comparison with asymptomatic athletes
(no-LBP), and to analyze the interplay of genetic and
behavioral/environmental factors in the development of
LBP in athletes.
Methods
Population
Study participants were enrolled consecutively for an
observational study approved by the Local Institutional
Ethical Committee of each participating institution, in
accordance with Declaration of Helsinki. All participants
signed a written informed consent before entering the study.
Italian white unrelated athletes (age range 18–60
years) regularly performing 5 or more hours weekly of
sport activity, including training and competitions, were
recruited as volunteers into our study. A blood sample
was requested and a survey was conducted through a
questionnaire. Recruitment was performed through an-
nouncements at the Sport Sciences Campus in Gemona
of Udine University. Before being enrolled into the
study, each athlete was interviewed to assess whether he
or she fulfilled the following inclusion criteria: a) no sur-
gery for lumbar pathology; b) no acute severe traumatic
events such as a car accident that damaged the spine or
because of a contact injury in sport or due to poor
biomechanics; c) no documented medical history of
spondylolistesis (because this condition has specific
characteristics different from other common causes of
LBP [7, 15, 31, 32]; d) absence of any acute or chronic
disease (like scoliosis, cervical diseases, autoimmune
diseases, rheumatoid arthritis, osteoporosis, fibromyal-
gia, diabetes mellitus, cardiovascular disease, or tumors
etc.); e) no use of anabolic steroids or other doping sub-
stances; f ) no use of vitamin D supplementation; and g)
no pregnancy at study entry [7, 14, 33]. For inclusion in
the LBP cases subjects had to answer “yes” to the
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following questions: “Have you had in your life low back
pain for more than 1 day?”. “If yes, was this low back
pain bad enough to limit your usual activities, or change
your daily routine, or sports activities including
absenteeism from exercise training sessions, competi-
tions, absence from work and/or class attending for
more than 1 day (not due to menstruation)?” [7, 10, 34].
For inclusion in the control group (no-LBP) athletes had
to answer “no” to the question “Have you had in your life
low back pain for more than 1 day?”. In other words,
controls have never had episodes of low back pain lasting
for more than 1 day lifelong. Each participant completed a
questionnaire assessing demographic characteristics,
medical history, lifestyle habits (including smoking and
coffee drinking), and exposure to risk factors known as
potentially affecting the susceptibility to spine disorders
like family history of lumbar spine disorder (parents,
brothers or sisters) [7, 14, 20], job physical demand
for the majority of the working years (evaluated by
score: 0 = sedentary; 1 = light; 2 = medium; 3 = heavy)
[7, 14], exposure to vibrations as daily hours spent
driving or as a passenger in motorized vehicles [7, 14],
and weekly hours of physical exercise including athletic
training and competitions.
VDR-FokI polymorphism determination
Determination of VDR-FokI polymorphism was performed
as described after extraction of genomic DNA from EDTA-
venous blood samples [7, 33]. Genotypes were designated by
a capital letter F allele (C nucleotide) for absence, and by a
lowercase letter f allele (T nucleotide) for the presence of
the FokI endonuclease restriction site, respectively [7].
Personnel performing genetic analysis were blinded to study
subject data.
Statistical analysis
Normally distributed continuous data were presented as
mean ± standard deviation (SD). The Mann-Whitney U-
test was used for comparison of continuous variables.
The difference of proportions between specific geno-
types and allele groups was assessed by Pearson’s χ2-test
or Fisher’s exact test, as appropriate. Logistic regression
was performed to evaluate the difference of genotypes
and alleles between groups after adjustment for potential
LBP confounders [4, 14, 15]: age, sex, BMI, ever smok-
ing, exposure to vibrations, physical job demand, and
weekly hours of physical exercise (including athletic
training sessions and competitions). All tests were 2-
sided. P values <0.05 were considered statistically signifi-
cant, p < 0.10 values were considered a tendency. Statistical
analysis was performed using the Statistical Package for
Social Sciences (SPSS for Windows, SPSS Inc., Chicago,
IL, USA).
Results
Sport activities
Table 1 shows sport disciplines practiced by the 60 study
participants, of whom 16.7% were swimmers, followed
by soccer players (11.7%), volleyball players (11.7%),
rugby players (10.0%), and other disciplines.
Characteristics and habits of the study athletes and
comparison between athletes with and without LBP
Out of 60 participants 24 (40%) had declared LBP
episodes and 36 had no LBP episodes lifelong. Only 5
out of 24 LBP subjects reported having received medical
assistance as outpatient for LBP. On average LBP posi-
tive subjects had 3.1 ± 3.0 LBP episodes lifelong. How-
ever, none of the subjects declaring the LBP symptom
had a specific medical diagnosis [7], accordingly, they
were non-specific LBP cases [9, 10].
Table 2 illustrates main characteristics and lifestyle
habits of study athletes, and comparison between the 24
athletes with LBP and 36 athletes without LBP episodes.
Thirty-eight percent (23/60) of participants were elite
athletes with national and/or international competitive
experience; the remaining athletes (61.7%, 37/144) were
non-elite athletes competing at regional levels (mostly in
Friuli-Venezia-Giulia Region, Northern Italy).
Participants performed on average 7.8 ± 3.3 h (range
5–22 h) weekly of regular physical activity including
training and competitions, they were 33.9 ± 13.3 years-
old, most had university level education, the majority of
subjects were not married, and all were of middle-class
socioeconomic status. The average BMI was 23.5 ±
3.5 kg/m2; the majority of athletes (44/60, 73.3%) were
in the normal weight range (BMI ≥18 and ≤25 kg/m2), 1
was an underweight female swimmer (BMI <18 kg/m2,
1.7%), and 15 were overweight athletes (BMI >25 kg/m2,
Table 1 Sport activities of 60 Italian athletes
Sport discipline N (%)
Swimming 10 (16.7)
Soccer 7 (11.7)
Volleyball 7 (11.7)
Rugby 6 (10.0)
Weight lifting 5 (8.3)
Track-and-field sports 5 (8.3)
Figure skating 4 (6.7)
Artistic gymnastics/competitive dancing 4 (6.7)
Basketball 3 (5.0)
Triathlon 3 (5.0)
Sailing 3 (5.0)
Discus throw 2 (3.3)
Martial arts 1 (1.7)
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25.0%) of which 2 (both male rugby players) had BMI
>30 kg/m2. Few athletes were current smokers (11.7%),
had ever smoked (i. e. past or current smokers) were
28.3%, however, only 10.0% of study participants ever
smoked 11 or more cigarettes per day in their lifetime.
As shown in Table 2, LBP athletes were not different
from no-LBP athletes with regard to the majority of the
studied parameters. In particular, athletes with LBP did
no more hours of athletic training and competitions
weekly, were not more frequently elite athletes, did not
differ by sex, age, BMI, smoking status, and did not had
a more physically intense job than athletes without LBP.
However, LBP athletes were more frequently exposed to
vibration for ≥2 h per day (OR = 3.54, 95% CI 1.18–10.7,
P = 0.022), and more frequently had a family history of
lumbar pathology (OR = 9.21, 95% CI 1.00–84.7, P =
0.033) than no-LBP athletes.
Table 3 shows frequencies of VDR-FokI genotypes and
alleles in all 60 athletes and illustrates comparisons of values
in 24 LBP cases versus 36 no-LBP controls. The homozy-
gous FF genotype was present in 58.3% of LBP cases versus
27.8% of no-LBP controls with significant risky crude OR=
3.64 and adjusted OR= 5.78. The heterozygous Ff genotype
was less frequent in LBP cases (41.7%) than in no-LBP con-
trols (66.7%), with significant protective adjusted OR= 0.24.
The homozygous genotype ff was found in none of LBP
cases, and in 5.6% of no-LBP controls. The F allele had a fre-
quency of 79.2% in LBP cases versus 61.1% in no-LBP con-
trols, with significant risky crude OR= 2.42, and adjusted
OR= 2.55, consequently the f allele was protective for LBP.
Discussion
At present, the scientific interest in the risk factors for
LBP is increasing both for athletic performance and
Table 2 Demographic and behavioral characteristics of 60 study athletes, comparison between the 24 athletes with LBP and 36 athletes
without LBP episodes
Characteristic All study athletes
(n = 60)
LBP
(n = 24)
No-LBP
(n = 36)
P value
Sport activity, hours/week, mean ± SD 7.8 ± 3.3 7.4 ± 3.4 8.1 ± 3.2 0.16b
Elite (national/international experience), n (%) 23 (38.3) 7 (29.2) 16 (44.4) 0.23c
Non-elite, n (%) 37 (61.7) 17 (70.8) 20 (55.6) 0.23c
Female, n (%) 25 (41.7) 11 (45.8) 14 (38.9) 0.59c
Male, n (%) 35 (58.3) 13 (54.2) 22 (61.1) 0.59c
Age, years, mean ± SD 33.9 ± 13.3 31.6 ± 12.4 35.5 ± 13.8 0.26b
Age at first LBP episode, years, mean ± SD 23.1 ± 9.5 23.1 ± 9.5 – –
Number of LBP episodes, mean ± SD 3.1 ± 3.0 3.1 ± 3.0 – –
Weight, kg, mean ± SD 72.4 ± 14.7 74.1 ± 11.6 71.2 ± 16.5 0.33b
Height, m, mean ± SD 174.9 ± 8.3 176.2 ± 7.6 174.1 ± 8.8 0. 46b
BMI, kg/m2, mean ± SD 23.5 ± 3.5 23.8 ± 3.0 23.2 ± 3.9 0.29b
BMI≥ 25, kg/m2, n (%) 15 (25.0) 6 (25.0) 9 (25.0) 1.00c
University/College, n (%) 40 (66.7) 19 (79.2) 21 (58.3) 0.094c
Married or separated/divorced, n (%) 25 (41.7) 8 (33.3) 17 (47.2) 0.28c
Current smoker, n (%) 7 (11.7) 3 (12.5) 4 (11.1) 1.00d
Ever (current or past) smoker, n (%) 17 (28.3) 7 (29.2) 10 (27.8) 0.91c
6 or more cigarettes/day ever smoker, n (%) 9 (15.0) 4 (16.7) 5 (13.9) 1.00d
11 or more cigarettes/day ever smoker, n (%) 6 (10.0%) 2 (8.3) 4 (11.1) 1.00d
Coffee drinkers, n (%) 50 (83.3) 22 (91.7) 28 (77.8) 0.29d
3 or more cups of coffee a/day, n (%) 19 (31.7) 9 (37.5) 10 (27.8) 0.43c
Exposure to vibrations ≥2 h/day 22 (36.7) 13 (54.2) 9 (25.0) 0.022c
Physical job demand more than sedentary 27 (45.0) 11 (45.8) 16 (44.4) 0.92c
Physical job demand more than medium 12 (20.0) 6 (25.0) 6 (16.7) 0.52d
Family history of lumbar pathologies 6 (10.0) 5 (20.8) 1 (2.8) 0.033d
aItalian espresso cups of coffee
bP comparison of LBP and no-LBP by two-tailed Mann-Whitney U-test
cP comparison of LBP and no-LBP by two-tailed Pearson’s chi squared test
dP comparison of LBP and no-LBP by two-tailed Fisher’s exact test, as appropriate
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health implications [9, 10]. Further research is required
in this field because discrepancies exist among studies
especially regarding LBP prevalence, causes, and thera-
peutic strategies [9, 12, 35]. In addition, sex-specific
studies are warranted to take into account sex differ-
ences in factors potentially modulating LBP [10, 14].
Some types of exercise seems to increase LBP prevalence
rate [8–10], but studies comparing athletes and non-
athletes do not always confirm this view [11, 36]. On the
other hand, some evidence suggests that exercise is
effective in preventing LBP [12, 35, 37].
The present observational study is the first to explore
the relationship of non-specific LBP in athletes with
VDR-FokI genotypes and alleles in a sample of 60 eth-
nically homogeneous white athletes practicing various
sport disciplines. We found that the frequency of the
homozygous FF genotype was higher in LBP athletes,
with adjusted OR = 5.78. On the contrary, the Ff geno-
type was protective (adjusted OR = 0.24). Our findings
highlighted that carriage of the F allele was a risk factor
(adjusted OR = 2.55), whereas carriage of the f allele was
protective for the development of LBP in athletes
(adjusted OR = 0.39).
Genotype and allele frequencies in our LBP group (FF
58.3, Ff 41.7, ff 0, F allele 79.2%) were different to those
reported in a study on 267 non-athletic patients with
lumbar spine pathologies (FF 43.8, Ff 44.9, ff 11.2, F
allele 66.3%) [7]. Our current findings in LBP athletes
are similar to those found in a study of 64 Italian non-
athletic patients who had discopathies (with or without
disc herniation) (FF 57.8, Ff 34.4, ff 7.8, F allele 75.0, and
f allele 25.0%). That study showed that the FF genotype
and the F allele were risk factors (OR = 2.02, 95% CI
1.15–3.55, P = 0.015, and OR = 1.76, 95% CI 1.13–2.75,
P = 0.012, respectively) by comparison to healthy non-
athletic controls [7]. Moreover, a group of 87 Italian
non-athletic patients with a medical diagnosis (by mag-
netic resonance imaging, MRI) of discopathies and/or
osteochondrosis associated with disc herniation had FF
rates of 56.3, Ff 36.8, ff 6.9, F allele 74.7, and f allele
25.3%. The odds ratio of FF was OR = 1.90, 95% CI
1.15–3.13, P = 0.012, and of F allele was OR = 1.74, 95%
CI 1.17–2.57, P = 0.005 [7]. Unfortunately, the design of
our present study was observational and, thus, we could
not assess radiologically whether study athletes with the
LBP symptom had a discopathy. Interestingly, Sward and
colleagues [38] found that disc degeneration, defined as
reduced disc signal intensity, was significantly more
common in elite gymnasts athletes (75%) than in non-
athletes (31%). There was also a significant correlation
between back pain and reduced disc signal intensity.
Moreover, a study by Ong and colleagues [39] examining
31 Olympic athletes of various disciplines with low back
pain found disc degeneration (assessed as reduced disc
signal intensity by MRI) in 62% of subjects and a
prevalence of disc displacement of 58%. The authors
suggested the opportunity for a change in the methods
of training to minimize disc degeneration, particularly at
the elite levels of sport [39].
Surprisingly, so far only 6 studies [40–45] have
assessed VDR-FokI polymorphism in athletesprior to the
current study. However, no previous studies have
examined the association of VDR-FokI polymorphism
with LBP in athletes. A study in 125 Italian soccer
players determined frequencies of FF 51.2, Ff 34.4, ff
14.4, F allele 68.4, and f allele 31.6% [40]. In this study,
the FF genotype was not related to different athletic per-
formance, but it was associated with higher values of the
ratio of body cell mass over fat-free mass (BCM/FFM)
[40]. Similarly, a study in 80 Italian white male gymnasts
participating at international competitions found no re-
lationship between the VDR-FokI polymorphism and
athletic performance [41]. In addition, 2 studies by
Massidda and colleagues in male Italian soccer players
found no correlation of VDR-FokI polymorphism with
athletic performance [42], and no association with inci-
dence or severity of musculoskeletal injury [43]. A study
by Nakamura and colleagues [44] in 44 Japanese male
Table 3 VDR-FokI genotypes and alleles in 60 athletes, and comparison between 24 athletes with LBP episodes and 36 athletes
without LBP episodes
VDR-FokI genotype or allele All athletes,
N = 60,
n (%)
LBP,
N = 24,
n (%)
No-LBP,
N = 36,
n (%)
Crude
OR (CI)
Crude
P value
Adjusteda
OR (CI)
Adjusteda
P value
FF genotype 24 (40.0) 14 (58.3) 10 (27.8) 3.64 (1.22–10.8) 0.018b 5.78 (1.41–23.8) 0.015
Ff
genotype
34 (56.7) 10 (41.7) 24 (66.7) 0.36 (0.12–1.04) 0.056b 0.24 (0.06–0.93) 0.039
ff genotype 2 (3.3) 0 (−) 2 (5.6) –c –c –c –c
F allele 82/120 (68.3) 38/48 (79.2) 44/72 (61.1) 2.42 (1.04–5.61) 0.037b 2.55 (1.02–6.43) 0.046
f allele 38/120 (31.7) 10/48 (20.8) 28/72 (38.9) 0.41 (0.18–0.96) 0.037b 0.39 (0.16–0.98) 0.046
aOR was adjusted by multivariate analysis for age, sex, BMI, ever smoking, exposure to vibrations, physical job demand, and weekly hours of physical exercise
bP comparison of LBP and no-LBP by two-tailed Pearson’s chi squared test
cOR not countable because one of the compared groups had zero subjects
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competitive athletes of various sport disciplines found
frequencies of FF of 50.0, and Ff 47.7%; FF carries when
compared to Ff carriers had 7.7% greater lumbar spine
bone mineral content (BMC) [44]. In contrast, a
Brazilian study examining 46 adolescent soccer players
(FF 41.3, Ff 47.8, ff 10.9, F allele 65.2, and f allele 34.8%)
found higher total body mineral content and density in
boys with Ff genotype compared to those with FF geno-
type [45].
By examining demographic and lifestyle characteris-
tics, we observed that daily exposure for 2 or more
hours to vehicle vibrations and family history of lumbar
spine pathologies were risk factors for LBP in athletes.
Similar results were previously observed for non-athletic
patients with lumbar pathologies, especially those with
discopathies and/or osteochondrosis associated with disc
herniation [7, 14]. We have shown in this study that ath-
letes with LBP were not older, were not more frequently
males, had no higher BMI, were not more frequently
smokers, and had no a more physically intense job than
no-LBP controls. On the contrary of previous findings
evidenced in non-athletic patients [7, 14]. Interestingly,
hours of physical exercise did not differ between LBP
and no-LBP athletes, conversely, non-athletic patients
with lumbar pathologies did less leisure physical activity
than healthy controls [7, 14].
In our study, BMI was not a risk factor for LBP. A
study in elite junior divers [1] found that a higher BMI
was a LBP risk factor for male but not female athletes. A
recent comprehensive review on risk factors of non-
specific LBP in athletes [9] found that there is moderate
evidence for high body weight as a risk factor.
Interestingly, Moradi and colleagues [9] reported that
there is insufficient evidence that amount of training per
week, active years in sport, age, and sex are associated
with LBP. We found that amount of weekly physical exer-
cise, age and sex were not risk factors for LBP in athletes.
Thus, our present findings seem to concur with most
accumulated evidence of risk factors for LBP in athletes.
The effect of smoking on LBP in athletes was poorly
investigated in previous studies [9], however, smoking in
athletes is much less frequent and intense than in non-
athletes [46].
Mechanisms leading to LBP in athletes still need to be
clarified. Further studies with increased number of
subjects, and also “ex vivo” research will be necessary to
evaluate the biochemical pathways relating the vitamin
D endocrine system to LBP.
Some evidence showed that FF genotype is associated
with increased lumbar spine bone mineral density
(BMD) [24, 44, 47]. Whether increased risk of LBP in
athletes due to carriage of F allele is mediated by higher
transcriptional activity of VDR and thus, higher bio-
logical efficacy of vitamin D in subjects with a specific
genetic background needs further investigations. Future
studies are warranted to assess if the observed increased
frequency of FF genotype and F allele in LBP athletes is
associated with up-regulation (or down-regulation) of
specific genes responsive to VDR action and associated
with lumbar spine pain. Interestingly recent studies
showed that a wide variety of hundreds of genes can be
affected by vitamin D [23, 26, 48]. Genome-wide studies
indicated the existence of up to 2776 VDR binding sites
in human genome [48]. Bioinformatic analysis has found
14,548 putative VDR binding sites; 16–21% of these sites
are located at gene promoters [23]. VDR binding at
VDREs may up- and down-regulate transcription of
genes in a tissue specific manner, this is also modulated
by epigenetic changes [23, 26].
Deeper understanding of biological pathways of vitamin
D related to LBP may indicate whether vitamin D rich diet
and/or supplementation should be recommended accord-
ing to VDR-FokI polymorphism. Recently, dietary and
vitamin supplementation were proposed to athletes having
LBP [9]. To our knowledge none so far suggested specific-
ally vitamin D supplementation to athletes with LBP.
Future studies will be necessary to assess this issue of per-
sonalized medicine [28, 49, 50].
It is generally recognized that LBP can negatively
affect athletic performance and recovery. Assessing the
predisposing and protective factors for LBP in athletes
may be complicated by several confounding factors,
among these VDR-FokI polymorphism may constitute a
major confounder as shown by our present findings.
There are limitations in our study. We studied adult
athletes, and thus, we cannot generalize these results to
younger or older athletes or athletes with different
ethnic backgrounds. Sport activities of athletes were
heterogeneous ranging from aerobic to mixed aerobic-
anaerobic and to anaerobic activity, and from elite to
non-elite competing level. We included several types of
sport disciplines but some other disciplines like tennis,
skiing, golf etc. were not assessed. However, we did not
prove a LBP association with elite status and hours of
physical exercise per week. In our study we examined non-
specific LBP thus our results cannot address other kinds of
LBP in athletes. In our study the confidence intervals were
somewhat large; however, significant results were obtained
after multivariate adjustments including several con-
founders. Finally, we evaluated LBP by a questionnaire and
we did performed radiological investigations.
Strengths of the present study include assessment of
LBP and VDR-FokI polymorphism in a homogeneous
ethnic group of competitive athletes, evaluation of
demographic, social, lifestyle characteristics and family
history, and stringent inclusion and exclusion criteria.
Further studies have to be carried out to expand
our observations including larger numbers of athlete
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practising different sport disciplines and to better as-
sess biochemical pathways related to vitamin D’s ef-
fects on LBP in athletes.
Conclusion
LBP in competitive athletes is under study, but risk factors
are still to be better investigated. This is the first study (to
our knowledge) demonstrating that a genetic trait of the
vitamin D system is associated with LBP in athletes. We
also investigated lifestyle habits of study athletes. We have
highlighted for the first time that some (although not all)
risk factors for LBP in the general non-athletic population
are also risk factors in athletes. We suggest that among
LBP risk factors examined in athletes, daily exposure to
vehicle vibrations and family history of lumbar pathologies
should be investigated. Identification of genetic and non-
genetic risk factors for LBP could be used by each athlete
to personalize training and lifestyle habits [51]. Further
studies with more defined LBP diagnosis by use of instru-
mental imaging techniques are needed.
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